simmitinib (SYHA1817) / CSPC Pharma  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
simmitinib (SYHA1817) / CSPC Pharma
NCT04058587: A Phase I Trial of Simmitinib in Advanced Solid Tumors

Recruiting
1
50
RoW
Simmitinib, SOMCL-15-290
CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Shanghai Runshi Pharmaceutical Technology Co., Ltd
Advanced Solid Tumor
01/23
03/23

Download Options